Johnson & Johnson's most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $105.00 short put and a strike $97.50 long put offers a potential 11.61% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $105.00 by expiration. The full premium credit of $0.78 would be kept by the premium seller. The risk of $6.72 would be incurred if the stock dropped below the $97.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.
The RSI indicator is at 65.26 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
FDA warns of serious allergic reactions with acne products
Wed, 25 Jun 2014 18:29:25 GMT
Reuters – The U.S. Food and Drug Administration warned on Wednesday that popular acne products sold over-the-counter under brand names such as Proactiv and Neutrogena can cause rare but serious and potentially life-threatening allergic reactions. The FDA said consumers should stop using their topical acne product and seek emergency medical help if they experience hypersensitivity reactions such as throat tightness, difficulty in breathing, feeling faint or swelling of the eyes, face, lips or tongue. The agency said it has received 131 reports of such hypersensitivity reactions from consumers or manufacturers, with the majority since 2012. The hypersensitivity reactions may occur within minutes to a day or longer after product use, the FDA said.
Johnson & Johnson: What If You Bought At These Highs?
Wed, 25 Jun 2014 17:50:08 GMT
Some Dividend ETFs Throw Their Weight Around
Tue, 24 Jun 2014 13:00:52 GMT
Johnson & Johnson: Buy The Dip…But Not Yet
Tue, 24 Jun 2014 12:57:35 GMT
Will GlaxoSmithKline plc Become A Bid Target?
Tue, 24 Jun 2014 07:57:33 GMT
Also on Market Tamer…
Follow Us on Facebook